Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria. 2002

Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
Center for Medical Parasitology, Department of Infectious Diseases, Copenhagen University Hospital and Institute for Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark. kkcmp@rh.dk

Levels of soluble CD30 (sCD30) in serum were elevated in patients with Plasmodium falciparum malaria but showed decline following treatment. The levels of sCD30 in serum were correlated significantly with the expression of gamma interferon by peripheral T cells. These data suggest that CD30(+) cells are upregulated during a malaria attack and that they may play a regulating role at the site of inflammation.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005869 Ghana A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. Gold Coast,Republic of Ghana
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
April 1994, Clinical and experimental immunology,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
June 1994, The Journal of infectious diseases,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
May 2000, Infection and immunity,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
April 1993, Immunology letters,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
July 1996, Clinical and experimental immunology,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
March 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
July 1988, Blood,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
September 1991, Journal of clinical microbiology,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
December 1988, The Journal of infectious diseases,
Kåre Kemp, and Jørgen A L Kurtzhals, and Bartholomew D Akanmori, and Victoria Adabayeri, and Bamenla Q Goka, and Charlotte Behr, and Lars Hviid
August 1989, The Journal of infectious diseases,
Copied contents to your clipboard!